Literature DB >> 16372020

Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain.

Saurabh Kumar Singh1, Rachna Hora, Hassan Belrhali, Chetan E Chitnis, Amit Sharma.   

Abstract

Molecular processes that govern pathogenic features of erythrocyte invasion and cytoadherence in malaria are reliant on Plasmodium-specific Duffy-binding-like domains (DBLs). These cysteine-rich modules recognize diverse host cell-surface receptors during pathogenesis. DBLs of parasite erythrocyte-binding proteins mediate invasion, and those from the antigenically variant P. falciparum erythrocyte membrane protein 1 (PfEMP1) have been implicated in cytoadherence. The simian and human malarial parasites, P. knowlesi and P. vivax, invade human erythrocytes exclusively through the host DARC receptor (Duffy antigen receptor for chemokines). Here we present the crystal structure of the P. knowlesi DBL domain (Pkalpha-DBL), which binds to DARC during invasion of human erythrocytes. Pkalpha-DBL retains the overall fold observed in DBLs from P. falciparum erythrocyte-binding antigen (EBA)-175 (ref. 4). Mapping the residues that have previously been implicated in binding highlights a fairly flat but exposed site for DARC recognition in subdomain 2 of Pkalpha-DBL; this is in sharp contrast to receptor recognition by EBA-175 (ref. 4). In Pkalpha-DBL, the residues that contact DARC and the clusters of residues under immune pressure map to opposite surfaces of the DBL, and suggest a possible mechanism for immune evasion by P. vivax. Our comparative structural analysis of Pkalpha-DBL and P. falciparum EBA-175 provides a framework for the understanding of malaria parasite DBLs, and may affect the development of new prophylactic and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16372020     DOI: 10.1038/nature04443

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  112 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

2.  Polymorphisms in erythrocyte binding antigens 140 and 181 affect function and binding but not receptor specificity in Plasmodium falciparum.

Authors:  Alexander G Maier; Jake Baum; Brian Smith; David J Conway; Alan F Cowman
Journal:  Infect Immun       Date:  2009-02-09       Impact factor: 3.441

3.  Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA.

Authors:  Morten A Nielsen; Vera V Pinto; Mafalda Resende; Madeleine Dahlbäck; Sisse B Ditlev; Thor G Theander; Ali Salanti
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

Review 4.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

5.  Characterisation of PfRON6, a Plasmodium falciparum rhoptry neck protein with a novel cysteine-rich domain.

Authors:  Nicholas I Proellocks; Lev M Kats; David A Sheffield; Eric Hanssen; Casilda G Black; Karena L Waller; Ross L Coppel
Journal:  Int J Parasitol       Date:  2008-11-27       Impact factor: 3.981

Review 6.  The apicomplexan glideosome and adhesins - Structures and function.

Authors:  Lauren E Boucher; Jürgen Bosch
Journal:  J Struct Biol       Date:  2015-03-09       Impact factor: 2.867

7.  Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies.

Authors:  Patchanee Chootong; Francis B Ntumngia; Kelley M VanBuskirk; Jia Xainli; Jennifer L Cole-Tobian; Christopher O Campbell; Tresa S Fraser; Christopher L King; John H Adams
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

8.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

9.  Insights into Duffy binding-like domains through the crystal structure and function of the merozoite surface protein MSPDBL2 from Plasmodium falciparum.

Authors:  Anthony N Hodder; Peter E Czabotar; Alessandro D Uboldi; Oliver B Clarke; Clara S Lin; Julie Healer; Brian J Smith; Alan F Cowman
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

Review 10.  Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.

Authors:  Francis B Ntumngia; Christopher L King; John H Adams
Journal:  Int J Parasitol       Date:  2012-10-12       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.